| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 214,388 | 253,355 | 268,667 | 269,845 | | Cost of Revenue | 71,806 | 93,442 | 102,492 | 116,558 | | | Gross Profit | 142,582 | 159,913 | 166,175 | 153,287 | | | Operating Expenses | | Research Development |
-
| 18,550 | 22,395 | 45,508 | | Selling General and Administrative | 114,760 | 80,567 | 90,562 | 78,257 | | Non Recurring | (49,861) | 3,115 | 4,009 | 2,231 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 77,683 | 57,681 | 49,209 | 27,291 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,420 | 19,023 | 2,291 | 3,046 | | Earnings Before Interest And Taxes | 79,103 | 76,704 | 51,500 | 30,337 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 79,103 | 76,704 | 51,500 | 30,337 | | Income Tax Expense | 28,056 | 28,323 | 16,548 | 8,755 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 51,047 | 48,381 | 34,952 | 21,582 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 51,047 | 48,381 | 34,952 | 21,582 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $51,047 | $48,381 | $34,952 | $21,582 |
|
0.17% Nasdaq 
Income Statement
